On November 7, 2025 TwoStep Therapeutics, a biotechnology company developing innovative, first-in-class, multispecific targeted peptide conjugate therapies for solid tumors, reported it will be presenting a poster at the Society for Immunotherapy of Cancer (SITC) (Free SITC Whitepaper)’s (SITC) (Free SITC Whitepaper) 40th Annual Meeting, being held November 7–9, 2025, at the Gaylord National Resort and Convention Center in National Harbor, MD.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Poster Presentation:
Title: A multi-integrin targeting peptide-drug conjugate induces durable tumor regression with a strong preclinical safety profile
Date and Time: Saturday, November 8, 2025
Abstract Number: 948
Authors: Yash Agarwal, Caleb Perez, Joy Geallis, Caitlyn Miller
Recognized among the Top 15% of accepted abstracts.

(Press release, TwoStep Therapeutics, NOV 7, 2025, View Source [SID1234659661])